Lawrence Einhorn, MD, in 2000-2001 and Dr. George Sledge in 2010-2011 served as prior presidents of American Society of Clinical Oncology (ASCO). Several IU School of Medicine faculty and former fellows serve in other leadership capacities for ASCO, including the Board of Directors.
Hal Broxmeyer, PhD, served as president of the American Society of Hematology (ASH) in 2010.
Several IU School of Medicine faculty and former fellows serve in leadership capacities as members of the Oncology Drug Advisory Committee (ODAC) to the FDA.
Several IU School of Medicine faculty and former fellows serve as editors of major oncology journals, including the Journal of Clinical Oncology (JCO).
First Row (Left to Right): Melissa Yan, MD; Nawal Kassem, MD; Sravanti Rangaraju, MD; Marwan Mounayar, MD; Nikhil Shukla, MD
Second Row (Left to Right): Steve Green, MD; Mustafa Hyder, MD; Adam Miller, MD (Chief); Jordan Maryfield, MD; Andrew O’Brien, MD; Nabin Khanal, MD; Vaibhav Agrawal, MD
Absent: Alvaro Menendez, MD; Shahid Ahmed, MD; Karam Al-Issa, MD
The Hematology Oncology Fellowship program at IU School of Medicine is customizable to meet the career goals of training physicians. The school devotes a major teaching effort to maximize the likelihood that fellows gain all requisite skills to compete successfully for research funding in academia and to be optimally prepared for careers in academic medicine as teacher- investigators. At the same time, fellows are preparing for a successful career in general hematology/oncology in a private practice setting. The program provides outstanding clinical training, excellent mentoring, and the ability to adapt the training experience to meet individual professional goals, within a nuturing and collegial atmosphere.
The Division of Hematology/Oncology at Indiana University School of Medicine offers a combined three year program. Fellows are offered the opportunity to be eligible for board certification in both disciplines of Hematology and Medical Oncology. Fellows also have the option of pursuing a two year program in one of the two sub-specialties. The number of fellows in the combined program is variable, based upon individual research interests of senior fellows. In general, 15 fellowship positions are available. The program has received the highest level of accreditation by the ACGME with a maximum cycle length of five years. During the period from 2013 to 2015, all (100 percent) of IU School of Medicine Hematology Oncology fellows who were eligible for and elected to take ABIM certifying exams in Hematology and Medical Oncology received passing scores.
Teaching and Mentorship
|Weekly Case Conference and Lecture Series||Immersion week for first year fellows, providing protected time to focus on learning core principles of hematology/oncology and concentrated orientation experience|
|Weekly Lymphoma/Leukemia Fellows conference||Research Foundation Workshop, designed to educate fellows on the basic skills of protocol and grant writing. Fellows are encouraged to apply for funding via this educational series.|
|Weekly Cancer Center Grand Rounds|
|Monthly Oncology Journal Club|
|Monthly Academic “Half-Day,” a unique learning experience with a Meet the Professor component|
|Monthly Chief Rounds|
|Annual ASCO Review Course|
|Landmark Trials Series and Board Review Materials|
This training program is in the heart of downtown Indianapolis. Fellows enjoy spending time together outside of work exploring Indianapolis, including Mass Ave, Broad Ripple and the Canal. More information about the IU School of Medicine–Indianapolis campus and local events reinforce the vibrant livability of this city.